Tumor Necrosis Factor Receptor-associated Factor Family Protein 2 is a Key Mediator of the Epidermal Growth Factor-induced Ribosomal S6 Kinase 2/Camp-Responsive Element-binding Protein/Fos Protein Signaling Pathway*

Cong Peng,Feng Zhu,Weihong Wen,Ke Yao,Shengqing Li,Tatyana Zykova,Kangdong Liu,Xiang Li,Wei-Ya Ma,Ann M. Bode,Zigang Dong
DOI: https://doi.org/10.1074/jbc.m112.359521
IF: 5.485
2012-01-01
Journal of Biological Chemistry
Abstract:Background: TRAF2 function in the EGF pathway and colon cancer development is unclear. Results: Knockdown TRAF2 blocked EGF- induced cell transformation and EGF signaling pathway through RSK2 ubiquitination. Conclusion: TRAF2 has an important function in the EGF pathway and is overexpressed and required in colon cancer development. Significance: TRAF2 regulates the EGF pathway through RSK2/CREB/c-Fos and is important for colon cancer development. TRAF2 has an important function in mediating the TNF-R signaling pathway toward activation of NF-κB and JNKs. Here we reveal a novel function of TRAF2 in the epidermal growth factor (EGF) signaling pathway. Knockdown of TRAF2 blocked EGF-induced AP-1 activity and anchorage- independent cell transformation. Notably, we showed that EGF induces ribosomal S6 kinase 2 (RSK2) ubiquitination, and knocking down TRAF2 suppresses ubiquitination of RSK2 induced by EGF. We also found that TRAF2 affects RSK2 activity through RSK2 ubiquitination. RSK2 plays a critical role in AP-1 activity mediated through CREB and c-Fos, which regulates anchorage-independent cell transformation. In addition, TRAF2 is overexpressed in colon cancer and required for colon cancer development, suggesting that TRAF2 might be a potential molecular target for cancer prevention and treatment.
What problem does this paper attempt to address?